Filtered By:
Source: MDDI
Condition: Diabetes
Education: Conferences
This page shows you your search results in order of relevance.
Order by Relevance | Date
Total 2 results found since Jan 2013.
AI Solutions Continue to Catch FDA & #039;s Eye
FDA has given a nod to yet another artificial intelligence (AI)-based technology. This time the agency has granted a De Novo request to market IDx’s AI-based diagnostic system for the autonomous detection of diabetic retinopathy, which can lead to blindness.
The Coralville IA-based company’s IDx-DR diagnostic received expedited review under the FDA's Breakthrough Devices program.
Earlier this year, the company told MD+DI that it met its endpoints in a pivotal trial of the IDx-DR system. The trial involved 900 diabetes patients at 10 sites. The study was designed to evaluate the diagnostic accuracy of the technology in ...
Source: MDDI - April 12, 2018 Category: Medical Devices Authors: Omar Ford Tags: Business Digital Health Source Type: news
Defining Innovation
Whatâs behind the record-breaking growth shared in EYâs 2019 âPulse of the Industryâ medtech report? Innovation, along with plenty of opportunities to solve some unmet needs.
âWe are at an awesome time in terms of innovation,â explained Ashley McEvoy, worldwide chairman, medical devices, Johnson & Johnson. Technology can now reach once-difficult-to-access anatomy, and miniaturization can enable earlier intervention, she pointed out as notable advances.
McEvoy was part of EYâs â...
Source: MDDI - October 2, 2019 Category: Medical Devices Authors: Daphne Allen Tags: Business Source Type: news